Skip to content

ConMed

US · CNMD #3018 by market cap Listed 1970
46.56 +0.18 +0.39%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 46.84 +0.99%
After-hours 46.56 0.00%
Overnight 46.59 +0.45%
53.6632.1146.562026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on CNMD?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is +2.6% on average (3-month/1-year).
  • Main-fund capital flow has been a net inflow over the last 45 sessions.
  • Short interest has fallen to 6.2% of float.
  • Analyst tilt is Hold.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days C → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall B+
ValuationGrowthProfitMomentumHealthAnalyst
Valuation B+

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 19.3x Better than 44%
Forward P/E 12.6x Better than 66%
Price / Sales 1.1x Better than 75%
P/E vs own 5-yr range 49th pctl Better than 60%
Growth A

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 9.6% Better than 63%
Net income CAGR (3Y) 28.4% Better than 79%
Free cash flow CAGR (3Y) 135.3% Better than 96%
Profitability C+

How much profit the business keeps from each dollar of sales and capital.

Gross margin 54.6% Better than 69%
Operating margin 7.5% Better than 43%
Net margin 3.4% Better than 38%
Return on equity 4.7% Better than 36%
Return on invested capital 3.6% Better than 39%
Momentum B+

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -8.8% Better than 53%
6-month return 25.1% Better than 87%
12-month return (ex latest month) 15.1% Better than 53%
Distance below 52-week high 15.0% Better than 71%
Financial Health B

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 2.1x Better than 59%
Debt to assets 35.9% Better than 32%
Interest coverage 3.3x Better than 47%
Free cash flow / net income 320.7% Better than 87%
Analyst View F

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 0.0% Better than 0%
Upside to average target 6.3% Better than 10%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -7.97%
1M -2.14%
3M -9.38%
6M +25.80%
YTD +14.68%
1Y +14.60%
3Y -56.20%
5Y -65.94%

Key statistics

Price & volume

Prev close
46.38
Open
46.11
Day range
45.94 - 48.00
Avg price
46.53
Volume
384.32K
Turnover
17.88M
Amplitude
4.44%
52-week range
31.44 - 54.80

Valuation

P/E
30.83
P/E (TTM)
19.32
P/B
1.31
EPS
1.51
Net profit
45.00M
Net assets
1.06B

Share structure

Market cap
1.39B
Float cap
1.37B
Shares out
29.80M
Float shares
29.51M

Dividend & listing

Dividend (TTM)
0.00
Listing date
1970-01-01
52-week range 65% of range
31.44 54.80

15.0% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

+2.66M net over the window

Short interest

Shares short
1.86M
As of
2026-10-30

Frequently asked questions

What is the current stock price of ConMed (CNMD)?

ConMed last traded at 46.56. This page shows a periodic quote snapshot. Check the displayed quote time.

What is ConMed's market cap?

About 1.39B.

What is the P/E ratio of ConMed?

The trailing twelve-month P/E is 19.32, above its own 5-year average of 19.26 — in the middle of its historical range (48.64% percentile). See the Valuation tab for the full history.

Does ConMed pay a dividend?

ConMed does not currently pay a regular dividend.

Is ConMed a buy according to analysts?

The consensus of 3 analysts is a Hold rating, with an average 12-month price target of 49.50, which implies 6.3% upside from the current price. This is not investment advice.

What is ConMed's StockVane Quant Rating?

The StockVane Momentum strategy currently rates ConMed a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

ConMed discussion 0 comments

Add a comment